Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia
Fawaz Almutairi, Theresa C. Peterson, Michele Molinari, Mark J. Walsh, Ian Alwayn, Kevork M. Peltekian – 27 April 2009 – Hypercholesterolemia is a common problem among transplant recipients. Despite package‐insert warnings about the potential side effects of the use of statins in patients with chronic liver disease, they are often prescribed for liver transplant recipients. Unlike statins, ezetimibe acts through inhibition of enterohepatic recirculation of lipids.